Table 5.
Predictors of 5-year overall survival among cervical cancer patients (n=134).
| Predictor | Odds ratio | 95%CI | P value | |
|---|---|---|---|---|
| FIGO stage | ||||
| I | Reference level | |||
| II | 1.69 | 0.18 | 16.17 | .647 |
| III | 0.46 | 0.04 | 5.08 | .528 |
| IV | NC | NC | NC | .999 |
| Grade | ||||
| I | Reference level | |||
| II | 0.15 | 0.03 | 0.81 | .027 |
| III | 0.09 | 0.02 | 0.57 | .010 |
| Right pelvis (yes) | 0.46 | 0.07 | 3.19 | .435 |
| Left pelvis (yes) | 0.29 | 0.03 | 2.47 | .258 |
| Bladder (yes) | 0.55 | 0.08 | 3.72 | .543 |
| Vagina (yes) | 0.69 | 0.24 | 1.95 | .483 |
| No. local involvement | ||||
| 0 | Reference level | |||
| 1-3 | 0.60 | 0.06 | 5.94 | .660 |
| 4+ | 3.87 | 0.13 | 117.68 | .438 |
| Distal metastasis (yes) | NC | NC | NC | .999 |
| Hydronephrosis (yes) | 0.46 | 0.06 | 3.32 | .442 |
| Recurrence (yes) | 0.18 | 0.07 | 0.47 | .001 |
Multivariate binary logistic regression. Independent variable = survival at 5 years of FU. NC: not computable. Model fit measures: deviance=127, AIC=157, R2(McFadden)=0.291, R2 (Nagelkerke)=0.441.